Menorah Medical Center | |
5721 West 119th Street, Overland Park, Kansas 66209 | |
(913) 498-6773 | |
Name | Menorah Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 5721 West 119th Street, Overland Park, Kansas |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 170182 |
NPI Number | 1255378337 |
Organization Name | MIDWEST DIVISION - MMC, LLC |
Doing Business As | MENORAH MEDICAL CENTER |
Address | 5721 W 119th St, Overland Park, KS 66209 |
Hospital Type | General Acute Care Hospital |
Phone Number | 913-498-6000 |
News Archive
Each year, more than 2 million infants and women around the world die from childbirth-related complications, according to a study released Tuesday at the International Federation of Gynecology and Obstetrics world congress in Cape Town, South Africa, the Associated Press reports.
Africa has the highest death rates in the world among critically ill COVID-19 patients, with limited intensive care resources a major factor, a study says.
Should glaucoma patients seeking alternative therapies trust what they find online? Are seatbelts still important to protect eyes in auto accidents, now that most cars have airbags? What's the connection between hearing loss and one form of glaucoma? These are among the topics explored in the March 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.
Boston Scientific Corporation announces CE Mark and European market launch of the Innova Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular lesions in arteries above the knee, specifically the superficial femoral artery (SFA) and proximal popliteal artery (PPA). The company plans to launch the product immediately in Europe and other CE Mark countries.
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
› Verified 1 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Each year, more than 2 million infants and women around the world die from childbirth-related complications, according to a study released Tuesday at the International Federation of Gynecology and Obstetrics world congress in Cape Town, South Africa, the Associated Press reports.
Africa has the highest death rates in the world among critically ill COVID-19 patients, with limited intensive care resources a major factor, a study says.
Should glaucoma patients seeking alternative therapies trust what they find online? Are seatbelts still important to protect eyes in auto accidents, now that most cars have airbags? What's the connection between hearing loss and one form of glaucoma? These are among the topics explored in the March 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology.
Boston Scientific Corporation announces CE Mark and European market launch of the Innova Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular lesions in arteries above the knee, specifically the superficial femoral artery (SFA) and proximal popliteal artery (PPA). The company plans to launch the product immediately in Europe and other CE Mark countries.
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
› Verified 1 days ago
Overland Park Reg Med Ctr Acute Care Hospital Location: 10500 Quivira Road, Overland Park, Kansas 66215 Phone: (913) 541-5000 | |
Menorah Medical Center Acute Care Hospital Location: 5721 West 119th Street, Overland Park, Kansas 66209 Phone: (913) 498-6773 | |
Saint Luke's South Hospital Acute Care Hospital Location: 12300 Metcalf Avenue, Overland Park, Kansas 66213 Phone: (913) 317-7904 | |
Pinnacle Regional Hospital, Inc Acute Care Hospital Location: 12850 Metcalf Avenue, Overland Park, Kansas 66213 Phone: (913) 220-2866 | |
Children's Mercy South Childrens Hospital Location: 5808 W 110th Street, Overland Park, Kansas 66211 Phone: (913) 234-3000 |